Synopsis
Synopsis
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Amdinocillin Pivoxil
2. Fl 1039
3. Fl-1039
4. Fl1039
5. Hydrochloride, Pivmecillinam
6. Mecillinam Pivaloyl Ester
7. Pivaloyl Ester, Mecillinam
8. Pivamdinocillin
9. Pivmecillinam Hydrochloride
10. Pivoxil, Amdinocillin
11. Selexid
1. Amdinocillin Pivoxil
2. 32886-97-8
3. Pivmecilinamo
4. Pivmecillinamum
5. Selexid
6. Amdinocillin Pivoxil [usan]
7. Pivmecilinamo [inn-spanish]
8. Pivmecillinamum [inn-latin]
9. Ro 10-9071
10. Amdinocillin, Pivaloyloxymethyl Ester
11. Pivmecillinam (inn)
12. Pivmecillinam [inn]
13. 1wam1oq30b
14. Amdinocillin Pivoxil (usan)
15. Ro-10-9071
16. Chebi:51210
17. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (2s-(2alpha,5alpha,6beta))-
18. Hydroxymethyl (2s,5r,6r)-6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate Pivalate (ester)
19. Coactabs
20. [(2,2-dimethylpropanoyl)oxy]methyl (2s,5r,6r)-6-[(azepan-1-ylmethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
21. [(2,2-dimethylpropanoyl)oxy]methyl 6beta-[(azepan-1-ylmethylidene)amino]-2,2-dimethylpenam-3alpha-carboxylate
22. Coactabs (tn)
23. 2,2-dimethylpropanoyloxymethyl (2s,5r,6r)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
24. Ncgc00016813-01
25. Cas-32887-03-9
26. Unii-1wam1oq30b
27. Sr-01000838842
28. Einecs 251-276-6
29. Prestwick0_001053
30. Prestwick1_001053
31. Prestwick2_001053
32. Prestwick3_001053
33. Pivmecillinam [jan]
34. Schembl33907
35. Schembl33908
36. Bspbio_001006
37. Pivmecillinam [mart.]
38. Spbio_002933
39. Pivmecillinam [who-dd]
40. Bpbio1_001108
41. Chembl1525183
42. Chembl1616433
43. Chembl1650818
44. Dtxsid7048538
45. Gtpl10922
46. Amdinocillin Pivoxil [mi]
47. Pivmecillinam, >=98% (hplc)
48. Bcp07843
49. Hy-b0810
50. Zinc4214799
51. Zinc13704173
52. Db01605
53. Ro-109071
54. Ncgc00179344-01
55. Ncgc00179344-04
56. Ncgc00179344-07
57. Ab00514713
58. D02889
59. A918810
60. Q418086
61. Sr-01000838842-2
62. Brd-k67100011-003-03-0
63. (2s,6r)-pivaloyloxymethyl 6-((e)-azepan-1-ylmethyleneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
64. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (2s-(2.alpha.,5.alpha.,6.beta.))-
Molecular Weight | 439.6 g/mol |
---|---|
Molecular Formula | C21H33N3O5S |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 8 |
Exact Mass | 439.21409234 g/mol |
Monoisotopic Mass | 439.21409234 g/mol |
Topological Polar Surface Area | 114 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 710 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Used to treat infections due to mecillinam-sensitive organisms such as urinary tract infections, salmonellosis and typhoid fever.
Pivmecillinam is a pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Anti-Infective Agents, Urinary
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01C - Beta-lactam antibacterials, penicillins
J01CA - Penicillins with extended spectrum
J01CA08 - Pivmecillinam
Absorption
Well absorbed following oral administration.
Pivmecillinam interferes with the biosynthesis of the bacterial cell wall however its activity is slightly different from that of other penicillins and cephalosporins
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
73
PharmaCompass offers a list of Pivmecillinam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pivmecillinam manufacturer or Pivmecillinam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pivmecillinam manufacturer or Pivmecillinam supplier.
PharmaCompass also assists you with knowing the Pivmecillinam API Price utilized in the formulation of products. Pivmecillinam API Price is not always fixed or binding as the Pivmecillinam Price is obtained through a variety of data sources. The Pivmecillinam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Selexid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Selexid, including repackagers and relabelers. The FDA regulates Selexid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Selexid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Selexid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Selexid supplier is an individual or a company that provides Selexid active pharmaceutical ingredient (API) or Selexid finished formulations upon request. The Selexid suppliers may include Selexid API manufacturers, exporters, distributors and traders.
click here to find a list of Selexid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Selexid DMF (Drug Master File) is a document detailing the whole manufacturing process of Selexid active pharmaceutical ingredient (API) in detail. Different forms of Selexid DMFs exist exist since differing nations have different regulations, such as Selexid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Selexid DMF submitted to regulatory agencies in the US is known as a USDMF. Selexid USDMF includes data on Selexid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Selexid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Selexid suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Selexid Drug Master File in Japan (Selexid JDMF) empowers Selexid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Selexid JDMF during the approval evaluation for pharmaceutical products. At the time of Selexid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Selexid suppliers with JDMF on PharmaCompass.
A Selexid CEP of the European Pharmacopoeia monograph is often referred to as a Selexid Certificate of Suitability (COS). The purpose of a Selexid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Selexid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Selexid to their clients by showing that a Selexid CEP has been issued for it. The manufacturer submits a Selexid CEP (COS) as part of the market authorization procedure, and it takes on the role of a Selexid CEP holder for the record. Additionally, the data presented in the Selexid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Selexid DMF.
A Selexid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Selexid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Selexid suppliers with CEP (COS) on PharmaCompass.
A Selexid written confirmation (Selexid WC) is an official document issued by a regulatory agency to a Selexid manufacturer, verifying that the manufacturing facility of a Selexid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Selexid APIs or Selexid finished pharmaceutical products to another nation, regulatory agencies frequently require a Selexid WC (written confirmation) as part of the regulatory process.
click here to find a list of Selexid suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Selexid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Selexid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Selexid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Selexid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Selexid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Selexid suppliers with NDC on PharmaCompass.
Selexid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Selexid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Selexid GMP manufacturer or Selexid GMP API supplier for your needs.
A Selexid CoA (Certificate of Analysis) is a formal document that attests to Selexid's compliance with Selexid specifications and serves as a tool for batch-level quality control.
Selexid CoA mostly includes findings from lab analyses of a specific batch. For each Selexid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Selexid may be tested according to a variety of international standards, such as European Pharmacopoeia (Selexid EP), Selexid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Selexid USP).